-
Image
As part of our ongoing efforts to advance the clinical evaluation of our products, we proudly participated in the IFCC Worldlab 2024, where we presented the results of studies conducted on liquid biopsy samples from cancer patients in poster presentations. These findings underscore the potential of our Oncolipsy products in enhancing cancer diagnostics, further validating their role in the clinical landscape of liquid biopsy.